Work

Supplementary Table S1 from A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

Year: 2025

Type: supplementary-materials

Abstract: Representativeness of Study Participants

DOI: 10.1158/1078-0432.28227551

Authors: Randy F. Sweis, Gurkamal S. Chatta, Rohit K. Jain, Helen Moon, Scott Edward Delacroix, Alana Fang, Leonard D’Amico, Angela Shaulov Kask, Martin A. Cheever, Steven Fling, Elad Sharon, Andreanne Lacroix, Judith C. Kaiser, Russell K. Pachynski, Evan Y. Yu

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4406541501

Cites:

Cited by:

Related to: 10